1 April 2023 false No description of principal activity Taxfiler 2024.6 4567617business:PrivateLimitedCompanyLtd2023-04-012024-03-31 45676172023-03-31 45676172023-04-012024-03-31 4567617business:AuditExempt-NoAccountantsReport2023-04-012024-03-31 4567617business:FilletedAccounts2023-04-012024-03-31 45676172024-03-31 4567617business:Director12023-04-012024-03-31 4567617business:RegisteredOffice2023-04-012024-03-31 45676172023-03-31 4567617core:WithinOneYear2024-03-31 4567617core:WithinOneYear2023-03-31 4567617core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 4567617core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 4567617core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 4567617core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-03-31 4567617core:PreviouslyStatedAmount2024-03-31 4567617core:PreviouslyStatedAmount2023-03-31 4567617business:SmallEntities2023-04-012024-03-31 4567617countries:EnglandWales2023-04-012024-03-31 4567617core:LandBuildings2023-04-012024-03-31 4567617core:FurnitureFittings2023-04-012024-03-31 4567617core:LandBuildings2023-03-31 4567617core:FurnitureFittings2023-03-31 4567617core:LandBuildings2024-03-31 4567617core:FurnitureFittings2024-03-31 4567617core:AdditionsToInvestments2024-03-31 4567617core:AfterOneYear2024-03-31 4567617core:AfterOneYear2023-03-31 45676172022-04-012023-03-31 iso4217:GBP xbrli:pure
Company Registration No. 4567617 (England and Wales)
Cochrane Opportunity Enterprises Limited Unaudited accounts for the year ended 31 March 2024
Cochrane Opportunity Enterprises Limited Unaudited accounts Contents
Page
- 2 -
Cochrane Opportunity Enterprises Limited Company Information for the year ended 31 March 2024
Director
Lyndsay Cochrane
Company Number
4567617 (England and Wales)
Registered Office
5 Commercial Street Ystradgynlais Swansea SA9 1HD United Kingdom
Accountants
RGS Accountants Limited 5 Commercial Street Ystradgynlais Swansea SA9 1HD
- 3 -
Cochrane Opportunity Enterprises Limited Statement of financial position as at 31 March 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
351,900 
480,610 
Investments
730,000 
- 
1,081,900 
480,610 
Current assets
Debtors
349,664 
299,837 
Cash at bank and in hand
121,368 
793,926 
471,032 
1,093,763 
Creditors: amounts falling due within one year
(5,930)
(9,206)
Net current assets
465,102 
1,084,557 
Net assets
1,547,002 
1,565,167 
Capital and reserves
Called up share capital
2 
2 
Profit and loss account
1,547,000 
1,565,165 
Shareholders' funds
1,547,002 
1,565,167 
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 21 August 2024 and were signed on its behalf by
Lyndsay Cochrane Director Company Registration No. 4567617
- 4 -
Cochrane Opportunity Enterprises Limited Notes to the Accounts for the year ended 31 March 2024
1
Statutory information
Cochrane Opportunity Enterprises Limited is a private company, limited by shares, registered in England and Wales, registration number 4567617. The registered office is 5 Commercial Street, Ystradgynlais, Swansea, SA9 1HD, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
NIL
Fixtures & fittings
Reducing balance: 25% per annum
4
Tangible fixed assets
Land & buildings 
Fixtures & fittings 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 April 2023
467,505 
100,869 
568,374 
Disposals
(115,605)
(100,869)
(216,474)
At 31 March 2024
351,900 
- 
351,900 
Depreciation
At 1 April 2023
- 
87,764 
87,764 
Charge for the year
- 
1,638 
1,638 
On disposals
- 
(89,402)
(89,402)
At 31 March 2024
- 
- 
- 
Net book value
At 31 March 2024
351,900 
- 
351,900 
At 31 March 2023
467,505 
13,105 
480,610 
- 5 -
Cochrane Opportunity Enterprises Limited Notes to the Accounts for the year ended 31 March 2024
5
Investments
Other investments 
£ 
Valuation at 1 April 2023
- 
Additions
730,000 
Valuation at 31 March 2024
730,000 
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Other debtors
103,152 
55,644 
Amounts falling due after more than one year
Other debtors
246,512 
244,193 
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Taxes and social security
3,530 
6,806 
Other creditors
2,400 
2,400 
5,930 
9,206 
8
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 6 -